DR. ROBERT W APPLING D.P.M.
Prescription History 1033432521
Podiatrist - Foot Surgery in Southaven, MS


Quality Rating: 78.34 out of 100 score

NPI Status: Active since March 11, 2010

Contact Information

5779 GETWELL RD
BLDG A SUITE 5
SOUTHAVEN, MS
ZIP 38672
Phone: (662) 470-5029
Fax: (662) 655-5174

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ROBERT W APPLING D.P.M., an active Foot Surgery specialist practicing in Southaven, MS. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 564 documented patient claims. Among these therapy options, the most frequently utilized medication is Terbinafine Hcl, which accounts for 89 claims alone.


Amoxicillin

Generic Formulation: AmoxicillinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.0
Days Supply 279
MS State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills38.7
Peer Average Days Supply301
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $80.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.45

State Avg Cost Per Claim

$4.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.

Therapeutic Applications

Amoxicillin is used to treat a wide variety of bacterial infections. This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning.

Cephalexin

Generic Formulation: CephalexinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 72
30-Day Fills 72.0
Days Supply 509
MS State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply389
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 132.3% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $284.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.96

State Avg Cost Per Claim

$7.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Clindamycin Hcl

Generic Formulation: Clindamycin HclSpecialty: Podiatry
Provider Metrics Summary
Total Claims 31
30-Day Fills 31.0
Days Supply 234
MS State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills23.6
Peer Average Days Supply207
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 34.8% more claims than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $230.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.42

State Avg Cost Per Claim

$10.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.

Therapeutic Applications

Clindamycin is used to treat a wide variety of bacterial infections. It is an antibiotic that works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Ketoconazole

Generic Formulation: KetoconazoleSpecialty: Podiatry
Provider Metrics Summary
Total Claims 75
30-Day Fills 75.0
Days Supply 1,423
MS State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills48.0
Peer Average Days Supply1,212
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 66.7% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,148.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.32

State Avg Cost Per Claim

$23.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.

Therapeutic Applications

This medication is used to control dandruff. Use of this medication may help to relieve the flaking, scaling and itching associated with dandruff. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Ketoconazole 2% shampoo is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs.

Lidocaine-Prilocaine

Generic Formulation: Lidocaine/PrilocaineSpecialty: Podiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 248
MS State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills19.6
Peer Average Days Supply430
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $275.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.18

State Avg Cost Per Claim

$24.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION.

Therapeutic Applications

This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts).

Meloxicam

Generic Formulation: MeloxicamSpecialty: Podiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 570
MS State Average Benchmarks
Peer Average Claims78.0
Peer Average 30-Day Fills135.5
Peer Average Days Supply3,966
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.6% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $202.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.67

State Avg Cost Per Claim

$6.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: Podiatry
Provider Metrics Summary
Total Claims 85
30-Day Fills 85.0
Days Supply 511
MS State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills36.4
Peer Average Days Supply240
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 136.1% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $674.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.93

State Avg Cost Per Claim

$8.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Mupirocin

Generic Formulation: MupirocinSpecialty: Podiatry
Provider Metrics Summary
Total Claims 73
30-Day Fills 73.0
Days Supply 1,318
MS State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills29.4
Peer Average Days Supply405
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 151.7% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $632.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.67

State Avg Cost Per Claim

$9.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Silver Sulfadiazine

Generic Formulation: Silver SulfadiazineSpecialty: Podiatry
Provider Metrics Summary
Total Claims 49
30-Day Fills 49.0
Days Supply 910
MS State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills18.9
Peer Average Days Supply380
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 172.2% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $279.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.70

State Avg Cost Per Claim

$17.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Antibacterial used topically in burn therapy.

Therapeutic Applications

This medication is used with other treatments to help prevent and treat wound infections in patients with serious burns. Silver sulfadiazine works by stopping the growth of bacteria that may infect an open wound. This helps to decrease the risk of the bacteria spreading to surrounding skin, or to the blood where it can cause a serious blood infection (sepsis). Silver sulfadiazine belongs to a class of drugs known as sulfa antibiotics. Silver sulfadiazine must not be used on premature babies or on newborns during the first 2 months of life because of the risk of serious side effects.

Ssd

Generic Formulation: Silver SulfadiazineSpecialty: Podiatry
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 582
MS State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills20.9
Peer Average Days Supply417
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $217.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.69

State Avg Cost Per Claim

$18.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Antibacterial used topically in burn therapy.

Therapeutic Applications

This medication is used with other treatments to help prevent and treat wound infections in patients with serious burns. Silver sulfadiazine works by stopping the growth of bacteria that may infect an open wound. This helps to decrease the risk of the bacteria spreading to surrounding skin, or to the blood where it can cause a serious blood infection (sepsis). Silver sulfadiazine belongs to a class of drugs known as sulfa antibiotics. Silver sulfadiazine must not be used on premature babies or on newborns during the first 2 months of life because of the risk of serious side effects.

Terbinafine Hcl

Generic Formulation: Terbinafine HclSpecialty: Podiatry
Provider Metrics Summary
Total Claims 89
30-Day Fills 170.2
Days Supply 4,715
MS State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills36.7
Peer Average Days Supply1,024
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 242.3% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $420.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.72

State Avg Cost Per Claim

$11.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Terbinafine is used to treat certain types of fungal infections (for example, of the fingernail or toenail). It works by stopping the growth of fungus. This medication belongs to a class of drugs known as antifungals.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. ROBERT W APPLING D.P.M. provides transparency into local medical care patterns within Southaven, MS.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Foot Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.